Today: 1 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Tesla Stock (TSLA) Today, November 24, 2025: AI Chip Push Meets New Legal and Trademark Risks

Tesla Stock (TSLA) Today, November 24, 2025: AI Chip Push Meets New Legal and Trademark Risks

Tesla shares rose about 1.5% in pre-market trading Monday to around $397 after Elon Musk highlighted the company’s in-house AI chip program. The stock closed Friday at $391.09 and remains volatile, down 3% year-to-date but up 11% over the past 12 months. Tesla’s market cap stands near $1.3 trillion, with a trailing P/E around 260–270. Legal developments in the U.S. and India also drew investor attention.
24 November 2025
···
Recursion Pharmaceuticals (RXRX) Stock Today: ‘Hold’ Rating, New Institutional Buying and AI Drug Discovery Hype — November 23, 2025

Recursion Pharmaceuticals (RXRX) Stock Today: ‘Hold’ Rating, New Institutional Buying and AI Drug Discovery Hype — November 23, 2025

Recursion Pharmaceuticals (RXRX) closed Friday at $4.17, up 8.31%, with volume near 33 million shares and trading near its 52-week low. MarketBeat reports a consensus “Hold” rating, with a $7.25 average price target and Q3 revenue down 80% year-on-year. Kingsview Wealth Management increased its RXRX stake by over 500% in Q2. About 89% of shares are institutionally held.
24 November 2025
···
Novavax Stock (NVAX) on November 24, 2025: Price, Sanofi Deal, Shah Capital Pressure and What It All Means for Investors

Novavax Stock (NVAX) on November 24, 2025: Price, Sanofi Deal, Shah Capital Pressure and What It All Means for Investors

Novavax (NASDAQ: NVAX) closed at $6.47 on Friday, up 4.0% but still 44% below its 52-week high. Q3 revenue beat estimates at $70 million, though losses widened and profitability is now targeted for 2028. Shah Capital is pressuring for a sale and threatening a proxy fight. The company expanded its Sanofi partnership, securing $225 million in milestones this year.
24 November 2025
·
3M (MMM) Stock Today, November 24, 2025: Fresh Valuation Calls, New PFAS Ruling and What’s Next for Investors

3M (MMM) Stock Today, November 24, 2025: Fresh Valuation Calls, New PFAS Ruling and What’s Next for Investors

3M shares closed at $168.09 on Friday, up 32% over the past year and trading just below their 52-week high. Q3 results showed organic sales growth above 3% and adjusted EPS up 10%, with full-year EPS guidance raised. Handelsbanken Fonder AB increased its stake by 17%. PFAS liabilities persist, though 3M won a procedural victory in Maine and maintains its dividend at $0.73 per share.
24 November 2025
·
Lyft Stock Today (November 24, 2025): Price, Fresh Headlines, Analyst Targets and 2026 Outlook

Lyft Stock Today (November 24, 2025): Price, Fresh Headlines, Analyst Targets and 2026 Outlook

Lyft closed at $19.78 on November 21, valuing the company at about $8 billion after a volatile month that saw the stock drop over 10% in two weeks. Shares remain up roughly 53% year-to-date but short interest is high, with nearly 17% of the public float sold short as of October 31. Trading volume Friday was just over 19 million shares, slightly below average. New legal and regulatory headlines emerged Monday.
24 November 2025
·
Constellation Energy (CEG) Stock Today, November 23, 2025: $1 Billion DOE Loan, AI Data Center Demand and What It Means for Investors

Constellation Energy (CEG) Stock Today, November 23, 2025: $1 Billion DOE Loan, AI Data Center Demand and What It Means for Investors

Constellation Energy closed Friday at $338.11, down 2.2% but up 51% year-to-date. The company secured a $1 billion U.S. Department of Energy loan to restart the 835 MW Crane Clean Energy Center by 2027. Institutional ownership exceeds 82%, with active options trading across a wide strike range. Analyst consensus targets imply about 15–16% upside from current levels.
24 November 2025
··
Marvell Technology (MRVL) Stock on November 23, 2025: Raymond James “Strong Buy” vs. Valuation Jitters Before Key AI Earnings

Marvell Technology (MRVL) Stock on November 23, 2025: Raymond James “Strong Buy” vs. Valuation Jitters Before Key AI Earnings

Marvell Technology closed Friday at $77.45, giving it a market cap near $66.8 billion after a 10% weekly drop and 31.8% year-to-date decline. Raymond James issued a new “strong buy” rating, while Bank Julius Baer cut its stake by 60%. A DCF analysis values the stock at $60. Marvell posted record Q2 revenue of $2 billion, up 58% year-on-year, driven by AI and data center demand.
24 November 2025
·
Carvana Stock (CVNA) Today, November 23, 2025: Deutsche Bank Initiation, Big 13F Moves and Q3 Momentum

Carvana Stock (CVNA) Today, November 23, 2025: Deutsche Bank Initiation, Big 13F Moves and Q3 Momentum

Carvana closed Friday at about $310 per share, valuing the company near $68 billion with a P/E ratio close to 71 and a beta of 3.5. Deutsche Bank initiated coverage with a “Buy” rating and a $395 target. Handelsbanken Fonder AB trimmed its stake by 5%, while Ensign Peak Advisors and Cetera Investment Advisers increased their holdings by 4.1% and 17.9%, respectively.
23 November 2025
··
Cloudflare Stock Today, November 23, 2025 (NET): Institutional Moves, Outage Fallout and the AI Story Behind the Volatility

Cloudflare Stock Today, November 23, 2025 (NET): Institutional Moves, Outage Fallout and the AI Story Behind the Volatility

Cloudflare shares opened Friday at $186.56, closing the week down sharply from early November highs near $260 after an internet outage and insider selling. The stock is up about 80% in 2025 but trades well below its 50- and 200-day averages. American Century trimmed its stake by 2% in Q2, while Bank Julius Baer cut holdings by 25.6%. Institutions control about 83% of Cloudflare’s float.
23 November 2025
··
Citigroup Stock Today (C): Price, Data‑Breach Fears, New CFO Shake‑Up and Q3 Momentum – November 23, 2025

Citigroup Stock Today (C): Price, Data‑Breach Fears, New CFO Shake‑Up and Q3 Momentum – November 23, 2025

Citigroup closed Friday at $98.70, up 1.1%, with shares up about 40–45% over the past year. A November 12 cyberattack on vendor SitusAMC may have exposed Citi client data, though the bank’s core systems were not affected. New filings show Journey Strategic Wealth and Neo Ivy Capital raised stakes in Citigroup, while Rhumbline Advisers trimmed its position. The next dividend payment is due November 26.
23 November 2025
··
NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics dissolved and began liquidation after filing a Certificate of Dissolution on June 26, 2024. Nasdaq delisted NBSE in May 2024; trading was suspended and shares are no longer listed on any exchange. Shareholders received $0.13 per share and a non-tradable escrow share for potential future payouts. No active market exists, despite some data vendors still showing outdated prices.
23 November 2025
·
Opendoor Technologies (OPEN) Stock Today: Hedge Fund Stake, Warrant Dividend and Valuation Jitters – November 23, 2025

Opendoor Technologies (OPEN) Stock Today: Hedge Fund Stake, Warrant Dividend and Valuation Jitters – November 23, 2025

Opendoor Technologies shares jumped 9.58% Friday to $6.75 after hedge fund D.E. Shaw disclosed a 6.4% stake. The stock has surged over 325% in 2025, swinging from a 52-week low of $0.51 to nearly $10.87. Most of D.E. Shaw’s position is held in a short-term trading fund. Analysts flag the move as tactical, with concerns the stock is outpacing fundamentals.
23 November 2025
··
Tonix Pharmaceuticals Stock on November 23, 2025: Tonmya Launch, Bigger Buyback, and a $400M ATM Shape the TNXP Trade

Tonix Pharmaceuticals Stock on November 23, 2025: Tonmya Launch, Bigger Buyback, and a $400M ATM Shape the TNXP Trade

Tonix Pharmaceuticals’ first commercial fibromyalgia drug, Tonmya, is now available in U.S. pharmacies following FDA approval in August. TNXP shares closed Friday at $16.10, up 2.94%, but remain down about 51% for 2025. Market cap stands near $141 million, with negative net margins and a price-to-sales ratio of 13.7. Expanded share repurchase and ATM equity programs are in place.
23 November 2025
··
Tilray Stock Today, November 23, 2025: TLRY Under $1 as AI Trading Signals, Hemp Rules and Big Holders Collide

Tilray Stock Today, November 23, 2025: TLRY Under $1 as AI Trading Signals, Hemp Rules and Big Holders Collide

Tilray Brands shares closed at $0.9059 on Friday, falling below $1 after a 12% weekly drop. Trading volume hit about 29.4 million shares, with a market cap near $1 billion. New AI-driven trading plans and regulatory uncertainty are drawing attention. The stock remains up over 90% from late-spring lows, fueled by U.S. cannabis policy speculation.
23 November 2025
····
Spirit Airlines Stock (FLYYQ) on November 23, 2025: Price, Second Bankruptcy, Class Actions and What Investors Need to Know

Spirit Airlines Stock (FLYYQ) on November 23, 2025: Price, Second Bankruptcy, Class Actions and What Investors Need to Know

Spirit Aviation Holdings (OTC: FLYYQ), parent of Spirit Airlines, traded at $0.25 per share Sunday, valuing the company at about $6.7 million after two Chapter 11 filings this year. Law firm Bronstein, Gewirtz & Grossman renewed calls for shareholders with losses to seek lead-plaintiff status in a class-action suit before a December 1 deadline. No new company press releases or SEC filings were issued today.
23 November 2025
···
Vistra (VST) Stock on November 23, 2025: Price, Fresh News and What Comes Next for the Nuclear‑Powered Utility

Vistra (VST) Stock on November 23, 2025: Price, Fresh News and What Comes Next for the Nuclear‑Powered Utility

Vistra closed Friday at $168.59, down 3% and about 22% below its September high, after a two-day slide on above-average volume. Q3 revenue missed estimates by 20%, but adjusted EBITDA reached $1.58 billion and 2025 guidance was raised. The board approved a $0.227 quarterly dividend and expanded buybacks, with $2.2 billion remaining. Eighteen analysts rate the stock “Buy” on average, with a $234.36 price target.
23 November 2025
··
1 … 579 580 581 582 583 584
Go toTop